​

Ernexa Therapeutics Ownership | Who Owns Ernexa Therapeutics?

OverviewFinancialsChart

Ernexa Therapeutics Ownership Summary

Ernexa Therapeutics is owned by 18.05% institutional investors, 41.78% insiders, and 40.17% retail investors. Bleichroeder lp is the largest institutional shareholder, holding 10.10% of ERNA shares. Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund, with 1.81% of its assets in Ernexa Therapeutics shares.

ERNA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockErnexa Therapeutics18.05%41.78%40.17%
SectorHealthcare Stocks 35.58%11.87%52.55%
IndustryBiotech Stocks 35.75%11.83%52.41%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bleichroeder lp2.00M10.10%$398.00K
Dauntless investment group612.44K3.09%$121.88K
Ci private wealth438.09K2.21%$87.18K
Geode capital management244.45K1.23%$48.64K
Xtx topco54.34K0.27%$10.81K
Warberg asset management50.00K0.25%$10.05K
Jane street group41.17K0.21%$8.19K
Citadel advisors33.08K0.17%$6.58K
Vanguard fiduciary trust25.45K0.13%$5.06K
Ubs group21.23K0.11%$4.22K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Dauntless investment group612.44K0.08%$121.88K
Bleichroeder lp2.00M0.07%$398.00K
Warberg asset management50.00K0.00%$10.05K
Sippican capital advisors10.00K0.00%$1.99K
Xtx topco54.34K0.00%$10.81K
Ci private wealth438.09K0.00%$87.18K
Montag a & associates8.00-$2.00
Eversource wealth advisors---
Vanguard personalized indexing management---
Two sigma securities---

Top Buyers

HolderShares% AssetsChange
Bleichroeder lp2.00M0.07%2.00M
Dauntless investment group612.44K0.08%612.44K
Geode capital management244.45K-220.83K
Xtx topco54.34K0.00%54.34K
Warberg asset management50.00K0.00%50.00K

Top Sellers

HolderShares% AssetsChange
Two sigma securities---229.34K
Citigroup---153.16K
Cypress point wealth management---94.38K
Vanguard personalized indexing management---67.62K
Naviter wealth---47.27K

New Positions

HolderShares% AssetsChangeValue
Bleichroeder lp2.00M0.07%2.00M$398.00K
Dauntless investment group612.44K0.08%612.44K$121.88K
Xtx topco54.34K0.00%54.34K$10.81K
Warberg asset management50.00K0.00%50.00K$10.05K
Jane street group41.17K-41.17K$8.19K

Sold Out

HolderChange
Group one trading-19.00
Morgan stanley-30.00
Jpmorgan chase-53.00
Fortitude family office-804.00
Eversource wealth advisors-1.75K

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202619-3,574,358-18-19---
Mar 31, 2025268.33%1,488,38549.68%25.25%129.09%525.00%
Dec 31, 20242420.00%994,39339.80%74.22%11120.00%433.33%
Sep 30, 2024205.26%711,29982.35%1325.29%5-3200.00%
Jun 30, 202419-13.64%390,079-4.67%712.60%5-28.57%1-

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Institutional Extnd Mkt Idx Tr142.08K1.81%115.58K
Fidelity Extended Market Index208.60K0.72%193.37K
Spartan Extended Market Index Pool F34.01K0.12%34.01K
Cinvest Azero Global FI13.43K0.05%-
BlackRock Extended Equity Market K2.28K0.04%-1.00
Fidelity Nasdaq Composite Index1.17K0.02%-
Vanguard Total Stock Mkt Idx Inv12.09K0.02%-
SSgA U.S. Extended Market Index Class I766.000.01%-
Fidelity Series Total Market Index3.19K0.01%-
Spartan Total Market Index Pool G1.83K0.01%-

Recent Insider Transactions

DateNameRoleActivityValue
Feb 10, 2026Cherington Charles-Buy$2.72M
Feb 10, 2026Cherington Charles-Buy$2.00M
Jun 09, 2025Cherington Charles-Buy$2.22M
Sep 24, 2024Cherington Charles-Buy$2.24M
Sep 24, 2024Cherington Charles-Buy-

Insider Transactions Trends

DateBuySell
2025 Q22-
2025 Q1--
2024 Q473
2024 Q34-
2024 Q2--

ERNA Ownership FAQ

Who Owns Ernexa Therapeutics?

Ernexa Therapeutics shareholders are primarily institutional investors at 18.05%, followed by 41.78% insiders and 40.17% retail investors. The average institutional ownership in Ernexa Therapeutics's industry, Biotech Stocks , is 35.75%, which Ernexa Therapeutics falls below.

Who owns the most shares of Ernexa Therapeutics?

Ernexa Therapeutics’s largest shareholders are Bleichroeder lp (2M shares, 10.10%), Dauntless investment group (612.44K shares, 3.09%), and Ci private wealth (438.09K shares, 2.21%). Together, they hold 15.41% of Ernexa Therapeutics’s total shares outstanding.

Does Blackrock own Ernexa Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Ernexa Therapeutics.

Who is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested?

Dauntless investment group is Ernexa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.08% of its assets in 612.44K Ernexa Therapeutics shares, valued at 121.88K$.

Who is the top mutual fund holder of Ernexa Therapeutics shares?

Vanguard Institutional Extnd Mkt Idx Tr is the top mutual fund holder of Ernexa Therapeutics shares, with 1.81% of its total shares outstanding invested in 142.08K Ernexa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools